Niki BioSolutions, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Niki BioSolutions, Inc. (NIKI) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $20.90 per share for the 6-month period ending 2023-06-30, per its 6-K filed 2023-12-22.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2023-12-22
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month as first filed | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|
| 2023-06-30 | $20.90 6-K · filed 2023-12-22 | |||
| 2022-12-31 | $25.25 20-F · filed 2023-04-28 | |||
| 2022-06-30 | $25.04 6-K · filed 2023-12-22 | $2.50 6-K · filed 2022-09-30 | ||
| 2021-12-31 | $36.52 20-F · filed 2023-04-28 | $3.65 20-F · filed 2022-04-29 | ||
| 2021-06-30 | $3.79 6-K · filed 2022-09-30 | |||
| 2020-12-31 | $49.27 20-F · filed 2023-04-28 | $4.92 20-F · filed 2021-04-19 | ||
| 2020-06-30 | $12.91 6-K · filed 2021-09-15 |